Repligen | RGEN - 贷款资金

股票价格

123.46

每天变化

-2.97 -2.35%

每月一次

3.07%

每年

0.18%

Q2 预测

114.76

金融业

USD

USD 2.93B

现金及等价物

USD 582.65M

USD 85.97M

USD 1.16B

USD 126.21M

USD 546.59M

USD 19.98M

USD 40.01M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 546.59M

USD 7.05B

USD 8.33M

USD 174.27M

USD 19.98M

普通股股本

USD 56.4M

109.48

USD 19.11M

USD 194M

销售和管理费用

USD 76.54M

USD 179.26M

贸易债权人

USD 34.66M

应收帐款人

USD 151.55M

	贷款资金	更改		日
Agilent	USD 3.05B		0	2025-12
Align Technology	USD 0		0	2024-12
Bio Techne	USD 200M		60M	2026-03
BioMarin Pharmaceutical	USD 1.43B		833.11M	2026-03
Bristol-Myers Squibb	USD 42.15B		698M	2026-03
Bruker	USD 1.66B		189.6M	2026-03
Charles River Laboratories	USD 2.66B		526.77M	2026-03
Danaher	USD 17.56B		855M	2026-03
Dentsply International	USD 2.01B		9M	2026-03
General Electric Aerospace	USD 18.17B		634M	2026-03
Henry Schein	USD 2.33B		17M	2026-03
Illumina	USD 1.49B		0	2026-03
IQVIA Holdings	USD 13.99B		105M	2026-03
Mettler Toledo International	USD 2.16B		73.35M	2026-03
Myriad Genetics	USD 120.3M		400K	2026-03
OraSure Technologies	USD 100K		17K	2025-12
Pacific Biosciences Of California	USD 645.38M		223K	2025-12
Pfizer	USD 60.57B		1.08B	2026-03
Repligen	USD 546.58M		4.37M	2026-03
Revvity	USD 2.63B		836K	2026-03
Standard Biotools	USD 299K		0	2025-12
Thermo Fisher Scientific	USD 40.07B		4.22B	2026-03
Waters	USD 5.22B		3.81B	2026-03
West Pharmaceutical Services	USD 202.8M		0	2026-03